Literature DB >> 25068414

Crystal structure of triple-BRCT-domain of ECT2 and insights into the binding characteristics to CYK-4.

Yang Zou1, Zhenhua Shao1, Junhui Peng1, Fudong Li1, Deshun Gong1, Chongyuan Wang1, Xiaobing Zuo2, Zhiyong Zhang1, Jihui Wu1, Yunyu Shi1, Qingguo Gong3.   

Abstract

Homo sapiens ECT2 is a cell cycle regulator that plays critical roles in cytokinesis. ECT2 activity is restrained during interphase via intra-molecular interactions that involve its N-terminal triple-BRCT-domain and its C-terminal DH-PH domain. At anaphase, this self-inhibitory mechanism is relieved by Plk1-phosphorylated CYK-4, which directly engages the ECT2 BRCT domain. To provide a structural perspective for this auto-inhibitory property, we solved the crystal structure of the ECT2 triple-BRCT-domain. In addition, we systematically analyzed the interaction between the ECT2 BRCT domains with phospho-peptides derived from its binding partner CYK-4, and have identified Ser164 as the major phospho-residue that links CYK-4 to the second ECT2 BRCT domain.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Auto-inhibition; Binding pocket; Phospho-peptide; The epithelial cell transforming protein 2; Triple-BRCT-domain

Mesh:

Substances:

Year:  2014        PMID: 25068414     DOI: 10.1016/j.febslet.2014.07.019

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.

Authors:  Verline Justilien; Kayla C Lewis; Kayleah M Meneses; Lee Jamieson; Nicole R Murray; Alan P Fields
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  A Non-canonical BRCT-Phosphopeptide Recognition Mechanism Underlies RhoA Activation in Cytokinesis.

Authors:  J Sebastián Gómez-Cavazos; Kian-Yong Lee; Pablo Lara-González; Yanchi Li; Arshad Desai; Andrew K Shiau; Karen Oegema
Journal:  Curr Biol       Date:  2020-07-02       Impact factor: 10.834

3.  DNA-PK promotes activation of the survival kinase AKT in response to DNA damage through an mTORC2-ECT2 pathway.

Authors:  Liu Liu; Xiaoming Dai; Shasha Yin; Pengda Liu; Elizabeth G Hill; Wenyi Wei; Wenjian Gan
Journal:  Sci Signal       Date:  2022-01-04       Impact factor: 9.517

4.  The RhoGAP activity of CYK-4/MgcRacGAP functions non-canonically by promoting RhoA activation during cytokinesis.

Authors:  Donglei Zhang; Michael Glotzer
Journal:  Elife       Date:  2015-08-07       Impact factor: 8.140

5.  Structure and regulation of human epithelial cell transforming 2 protein.

Authors:  Mengran Chen; Han Pan; Lingfei Sun; Peng Shi; Yikan Zhang; Le Li; Yuxing Huang; Jianhui Chen; Peng Jiang; Xianyang Fang; Congying Wu; Zhucheng Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-30       Impact factor: 11.205

6.  Plasma Membrane Association but Not Midzone Recruitment of RhoGEF ECT2 Is Essential for Cytokinesis.

Authors:  Kristýna Kotýnková; Kuan-Chung Su; Stephen C West; Mark Petronczki
Journal:  Cell Rep       Date:  2016-12-06       Impact factor: 9.423

7.  CYK-4 regulates Rac, but not Rho, during cytokinesis.

Authors:  Yelena Zhuravlev; Sophia M Hirsch; Shawn N Jordan; Julien Dumont; Mimi Shirasu-Hiza; Julie C Canman
Journal:  Mol Biol Cell       Date:  2017-03-15       Impact factor: 4.138

8.  Unraveling low-resolution structural data of large biomolecules by constructing atomic models with experiment-targeted parallel cascade selection simulations.

Authors:  Junhui Peng; Zhiyong Zhang
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

9.  Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling.

Authors:  Jayaprakash Periasamy; Vadiraj Kurdekar; Subbarao Jasti; Mamatha B Nijaguna; Sanjana Boggaram; Manjunath A Hurakadli; Dhruv Raina; Lokavya Meenakshi Kurup; Chetan Chintha; Kavyashree Manjunath; Aneesh Goyal; Gayathri Sadasivam; Kavitha Bharatham; Muralidhara Padigaru; Vijay Potluri; Ashok R Venkitaraman
Journal:  Cell Chem Biol       Date:  2018-03-29       Impact factor: 8.116

10.  ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.

Authors:  Iris Tanaka; Alina Chakraborty; Olivier Saulnier; Clara Benoit-Pilven; Sophie Vacher; Dalila Labiod; Eric W F Lam; Ivan Bièche; Olivier Delattre; Frédéric Pouzoulet; Didier Auboeuf; Stéphan Vagner; Martin Dutertre
Journal:  Nucleic Acids Res       Date:  2020-03-18       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.